Pomerantz LLP is investigating Cellectis S.A. for potential securities fraud following the company's announcement on September 14, 2026, that it would halt development of CAR-T cell therapies lasme-cel and eti-cel to focus on in vivo gene editing therapies. The decision was driven by financial constraints and timeline issues, leading to a sharp 40.97% drop in Cellectis's ADR price. This probe could impact investor confidence and the company's future funding strategies.
Cellectis S.A. is under investigation following its announcement to halt CAR-T cell therapy development. For readers following the health sector, here is Pluang's market snapshot as of Oct 08, 2026 19:42 WIB: of 128 priced US health stocks, 34 rose and 88 fell. Notable movers include NVAX at USD 11.00 with a 79% sell order activity, ALNY at USD 220.02 with 92% sell orders, and ABCL at USD 12.61 with 55% sell orders.
Pacira BioSciences was downgraded from Buy to Hold by Needham following Viatris's announcement to acquire the company for $36.50 per share, valuing it at about $1.65 billion. The deal is expected to close by late 2026 and will enhance Viatris's portf...
Seaport Global increased Shopify's price target from $175 to $180, reflecting an 8.3% upside from the current price of $166.16. Shopify's shares have surged 80% since May, pushing its market value above $205 billion. The rally is driven by a strategi...
Tesco reported earnings per share of $0.69, beating estimates of $0.64, despite revenue falling short at $44.60 billion versus $49.60 billion expected. The UK supermarket raised its full-year adjusted operating profit forecast to £3.15-3.30 billion, ...
CIQ has released Fuzzball 4.3, a platform that enables enterprises to deploy validated open-weight AI models and agents on their existing GPU infrastructure with a single command. This update simplifies operationalizing AI by automatically connecting...
As of September 30, 2026, Societe Generale's share capital consists of 739,264,232 shares with a total of 821,169,560 voting rights. The bank highlights its strong global presence with 110,000 employees serving 27 million clients across 58 countries....
